Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not

Kyung Won Park1, Hyun Jin Yoon, Do-Young Kang

  • 1Department of Neurology, Dong-A University College of Medicine, Busan, Republic of Korea. neuropark@dau.ac.kr

Psychiatry Research
|September 18, 2012
PubMed

Insights

Identifying early brain perfusion deficits in mild cognitive impairment (MCI) using technetium (Tc-99m) hexamethylpropyleneamine oxime (TC-99m HMPAO) single photon emission computed tomography (SPECT) can help predict Alzheimer's disease (AD) progression.

Area of Science:

  • Neuroimaging
  • Neurology
  • Geriatrics

Background:

  • Mild cognitive impairment (MCI) is a precursor to Alzheimer's disease (AD) and other dementias, characterized by heterogeneity.
  • Early detection of neurodegenerative changes in MCI is crucial for timely intervention and disease management.

Purpose of the Study:

  • To identify specific areas of initial cerebral hypoperfusion in MCI patients who convert to AD.
  • To compare baseline perfusion deficits between MCI converters, non-converters, and healthy controls using SPECT imaging.

Main Methods:

  • Recruited 49 MCI patients for brain MRI, neuropsychological testing, and Tc-99m HMPAO SPECT scans.
  • Utilized Statistical Parametric Mapping 8 (SPM8) software for voxel-based analysis of SPECT images.
  • Monitored patients for 1-2 years to determine conversion to dementia status.

Main Results:

  • Converted MCI patients showed hypoperfusion in the parahippocampal gyri and right precuneus compared to controls.
  • Non-converted MCI patients exhibited hypoperfusion in the left parahippocampal gyrus.
  • Converted MCI patients had significant hypoperfusion in the cingulate gyri and right precuneus compared to non-converters.

Conclusions:

  • Brain SPECT imaging can reveal early hypoperfusion patterns indicative of AD progression in MCI patients.
  • Identifying these perfusion deficits may aid in predicting which MCI individuals are at higher risk for developing AD.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...